SCI Pharmtech Inc. | Balance Sheet

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
753
568
802
865
671
791
Total Accounts Receivable
216
246
171
255
174
391
Inventories
407
510
554
498
483
503
Other Current Assets
11
6
9
5
12
22
Total Current Assets
1,387
1,330
1,536
1,623
1,339
1,707
Net Property, Plant & Equipment
1,555
1,776
1,785
1,762
1,786
1,884
Total Investments and Advances
30
50
42
42
42
75
Intangible Assets
-
-
-
-
1
47
Other Assets
36
43
56
81
74
24
Total Assets
3,053
3,221
3,457
3,550
3,296
3,789
ST Debt & Current Portion LT Debt
115
58
195
1
-
Accounts Payable
73
72
65
57
35
Income Tax Payable
16
25
73
44
37
Other Current Liabilities
188
242
340
353
271
Total Current Liabilities
391
397
673
455
343
Long-Term Debt
563
577
-
-
-
Provision for Risks & Charges
30
21
22
-
22
Deferred Taxes
44
21
37
40
53
Other Liabilities
-
-
-
23
-
Total Liabilities
985
995
695
479
366
Common Equity (Total)
2,068
2,226
2,762
3,071
2,930
Total Shareholders' Equity
2,068
2,226
2,762
3,071
2,930
Total Equity
2,068
2,226
2,762
3,071
2,930
Liabilities & Shareholders' Equity
3,053
3,221
3,457
3,550
3,296

About SCI Pharmtech

View Profile
Address
No. 61, Lane 209, Haihu North Road
Taoyuan 338 56
Taiwan
Employees -
Website http://www.sci-pharmtech.com.tw
Updated 07/08/2019
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. It focuses in the research, development, process, manufacture and sale of active pharmaceutical ingredient (API), API intermediates, and special and precision chemicals. The company's products are used for anti-epilepsy, anticonvulsant, sleeping pills, anesthesia, arrhythmia, antibiotics, anti-anorexia agents, smoking cessation drug, hypertension, antiparkinsonian, diet pills, anti-AIDS, steroid, and antidepressant.